Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG. Lenzen MJ, et al. Among authors: simoons ml. Eur Heart J. 2005 Dec;26(24):2706-13. doi: 10.1093/eurheartj/ehi499. Epub 2005 Sep 23. Eur Heart J. 2005. PMID: 16183692
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
Hordijk-Trion M, Lenzen M, Wijns W, de Jaegere P, Simoons ML, Scholte op Reimer WJ, Bertrand ME, Mercado N, Boersma E; EHS-CR Investigators. Hordijk-Trion M, et al. Among authors: simoons ml. Eur Heart J. 2006 Mar;27(6):671-8. doi: 10.1093/eurheartj/ehi731. Epub 2006 Jan 19. Eur Heart J. 2006. PMID: 16423872
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
Brugts JJ, Ninomiya T, Boersma E, Remme WJ, Bertrand M, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML. Brugts JJ, et al. Among authors: simoons ml. Eur Heart J. 2009 Jun;30(11):1385-94. doi: 10.1093/eurheartj/ehp103. Epub 2009 Apr 4. Eur Heart J. 2009. PMID: 19346520 Free article.
Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
Lenderink T, Boersma E, Gitt AK, Zeymer U, Wallentin L, Van de Werf F, Hasdai D, Behar S, Simoons ML. Lenderink T, et al. Among authors: simoons ml. Eur Heart J. 2006 Aug;27(15):1799-804. doi: 10.1093/eurheartj/ehl125. Epub 2006 Jul 4. Eur Heart J. 2006. PMID: 16820364
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation.
Lenzen MJ, Scholte op Reimer WJ, Pedersen SS, Boersma E, Maier W, Widimsky P, Simoons ML, Mercado NF, Wijns W; Euro Heart Survey on Coronary Revascularization. Lenzen MJ, et al. Among authors: simoons ml. Heart. 2007 Mar;93(3):339-44. doi: 10.1136/hrt.2005.086868. Epub 2006 Sep 15. Heart. 2007. PMID: 16980515 Free PMC article.
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte Op Reimer W, Simoons ML; Euro Heart Survey Investigators. Lenzen M, et al. Among authors: simoons ml. Eur Heart J. 2006 Dec;27(24):2969-74. doi: 10.1093/eurheartj/ehl363. Epub 2006 Nov 7. Eur Heart J. 2006. PMID: 17090612
533 results